Prot #D3258C00001: A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled 3-Part Phase 3 Study to Demonstrate the Efficacy and Safety of Benralizumab in Patients with Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study

  • Hirano, Ikuo (PD/PI)

Project: Research project

Project Details

StatusActive
Effective start/end date9/16/22 → 9/16/25

Funding

  • AstraZeneca Pharmaceuticals LP ((OE) Prot #D3258C00001)